NIH award emphasizes long-term relationship, says AMRI

By Melissa Fassbender contact

- Last updated on GMT

AMRI will support DPI scientists advance early-stage NCATS drug discovery projects. (Image: iStock/Totojang)
AMRI will support DPI scientists advance early-stage NCATS drug discovery projects. (Image: iStock/Totojang)

Related tags: Economics

AMRI has received a 5-year federal contract award from the National Institutes of Health (NIH) under which it will provide drug substance development and manufacturing services.

The award, from NIH’s National Center for Advancing Translational Sciences (NCATS), supports the Division of Pre-Clinical Innovation’s (DPI) drug development programs.

The goal of the DPI is to advance collaborative research projects across pre-clinical phases of the translational science spectrum​,” Chris Conway, senior vice president, discovery, development and analytical services at AMRI told Outsourcing-Pharma.com.

The global contract research and manufacturing organization (CRO) will provide services related to process development, analytical development and small-scale GMP manufacture of small molecule drug candidates for preclinical trials.

Conway explained task order requests for proposals will be circulated amongst all contractors under a particular technical area each time new work is needed.

Investment in additional capacity is not anticipated at this point in time, he said.

The contract emphasizes our long-term relationship with the NIH – we’ve been working with the NIH for years with great success, and we are proud that our relationship with the NIH has grown and matured​,” added Conway.

Related news

Show more

Related products

show more

Transforming Clinical Development

Transforming Clinical Development

PerkinElmer | 01-May-2021 | Technical / White Paper

The estimated cost of bringing a drug to market in the U.S. according to JAMA is $1 billion.1 The extreme cost of clinical trials urge biopharmaceutical,...

Q&A: Effective Drug Product Process Development

Q&A: Effective Drug Product Process Development

Catalent Pharma Solutions | 14-Jan-2021 | Insight Guide

In this Q&A, a Catalent Biologics expert shares his expertise with drug product process development challenges, risks and how to mitigate them, the...

Has EDC Kept Up With Changes In Clinical Trials?

Has EDC Kept Up With Changes In Clinical Trials?

Oracle Health Sciences | 14-Dec-2020 | Technical / White Paper

In just a few decades, clinical trials have changed dramatically. Twenty years ago, most of the data used in clinical research was entered on paper, but...

Related suppliers

Follow us

Products

View more

Webinars